Echo45 Advisors LLC increased its stake in shares of Chubb Limited (NYSE:CB – Free Report) by 5.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 964 shares of the financial services provider’s stock after acquiring an additional 53 shares during the quarter. Echo45 Advisors LLC’s holdings in Chubb were worth $262,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of CB. Continuum Advisory LLC boosted its holdings in shares of Chubb by 56.5% during the 3rd quarter. Continuum Advisory LLC now owns 97 shares of the financial services provider’s stock valued at $28,000 after purchasing an additional 35 shares during the last quarter. Kozak & Associates Inc. purchased a new stake in shares of Chubb in the third quarter worth about $29,000. Gordian Capital Singapore Pte Ltd bought a new position in Chubb during the third quarter valued at approximately $29,000. Raelipskie Partnership purchased a new position in Chubb during the 3rd quarter valued at approximately $29,000. Finally, Truvestments Capital LLC bought a new stake in Chubb in the 3rd quarter worth approximately $30,000. 83.81% of the stock is owned by hedge funds and other institutional investors.
Chubb Trading Down 0.2 %
NYSE CB opened at $268.21 on Thursday. The stock has a market cap of $108.11 billion, a PE ratio of 10.98, a PEG ratio of 7.29 and a beta of 0.67. The company’s 50-day moving average price is $277.39 and its 200-day moving average price is $278.72. Chubb Limited has a 12 month low of $238.85 and a 12 month high of $302.05. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.21.
Chubb Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Friday, December 13th were paid a $0.91 dividend. This represents a $3.64 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend was Friday, December 13th. Chubb’s dividend payout ratio (DPR) is presently 14.91%.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on CB. JPMorgan Chase & Co. increased their target price on Chubb from $294.00 to $296.00 and gave the company a “neutral” rating in a research report on Friday, January 3rd. Piper Sandler lifted their price objective on shares of Chubb from $281.00 to $305.00 and gave the stock an “overweight” rating in a research note on Friday, October 4th. Keefe, Bruyette & Woods boosted their target price on shares of Chubb from $320.00 to $328.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. Bank of America increased their price target on shares of Chubb from $275.00 to $282.00 and gave the company an “underperform” rating in a report on Thursday, October 10th. Finally, Evercore ISI boosted their price objective on Chubb from $289.00 to $293.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $288.17.
Get Our Latest Stock Analysis on CB
About Chubb
Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical risk, cyber risk, surety, and casualty; and group accident and health insurance to large, middle market, and small commercial businesses.
See Also
- Five stocks we like better than Chubb
- Why Invest in High-Yield Dividend Stocks?
- 2 ETFs to Maximize Gains With Covered Call Strategies
- Comparing and Trading High PE Ratio Stocks
- 3 Small-Cap Stocks Insiders and Institutions Are Buying
- Using the MarketBeat Dividend Tax Calculator
- MaxCyte: Building the Future of Cell and Gene Therapy Innovation
Want to see what other hedge funds are holding CB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chubb Limited (NYSE:CB – Free Report).
Receive News & Ratings for Chubb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chubb and related companies with MarketBeat.com's FREE daily email newsletter.